Immune-related adverse events in various organs caused by immune checkpoint inhibitors
Author:
Publisher
Elsevier BV
Subject
General Medicine,Immunology and Allergy
Reference105 articles.
1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012
2. A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors;Arnaud-Coffin;Int J Cancer,2019
3. The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis;Gu;BMC Cancer,2019
4. Not all immune-checkpoint inhibitors are created equal: meta-analysis and systematic review of immune-related adverse events in cancer trials;El Osta;Crit Rev Oncol Hematol,2017
5. Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review;Khoja;Ann Oncol,2017
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy;Biomarker Research;2024-09-04
2. A Case of Bullous Pemphigoid with Significant Infiltration of CD4-Positive T Cells during Treatment with Pembrolizumab, Accompanied by Pembrolizumab-Induced Multi-Organ Dysfunction;Diagnostics;2024-09-04
3. Toxicity profile of camrelizumab-based immunotherapy in older adults with advanced cancer;Scientific Reports;2024-08-16
4. PD-1/PD-L1 Provides Protective Role in Hypoxia-Induced Pulmonary Vascular Remodeling;Hypertension;2024-08
5. FLT3+ DC inhibits immune rejection via interaction with Treg in liver transplantation;International Immunopharmacology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3